Mo1053 A Phase 2, Randomized, Double-Blind, Parallel-Group, Multicenter, Dose-Ranging Study to Evaluate the Efficacy and Safety of a Novel Potassium-Competitive Acid Blocker (P-CAB) TAK-438 in Patients With Erosive Esophagitis

✍ Scribed by Chiba, Tsutomu; Sakurai, Yuuichi; Nishimura, Akira; Hiramatsu, Naoki; Umegaki, Eiji; Iwakiri, Katsuhiko; Ashida, Kiyoshi

• Book ID: 122243006
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 325 KB
• Volume: 144
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(13)62088-0